Industry news

11 August 2016

Miramar Labs, Inc. ® Reports Record Second Quarter 2016 Financial Results

Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company, announced today financial results for the second quarter ended June 30, 2016: Second quarter revenue of $7.4 million, up 47% year-over-year, year-to-date revenue of $11.7 million, up 46% year-over-year, shipped record number of miraDry® systems and consumables in the second quarter

11 August 2016

Neothetics Provides Business Update and Reports Second Quarter 2016 Financial Results

Neothetics, Inc.  (NASDAQ:NEOT) today provided a business update on its strategic and operational initiatives and reported financial results for the second quarter 2016.

Portable Device Delivers Biopharmaceuticals on Demand

BioPharm International

Biopharmaceutical drugs typically are produced through a lengthy process in large scales at dedicated bioprocessing facilities. The finished drug product must then be shipped under controlled conditions to reach the treatment site. When patients are in remote regions with limited supply chain or transportation infrastructure, the delivery can be compromised.

Pfizer Strengthens its Gene Therapy Program by Acquiring Bamboo Therapeutics

BioPharm International

Pfizer has acquired Bamboo Therapeutics, a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies for the potential treatment of patients with certain rare diseases related to neuromuscular conditions and those affecting the central nervous system.

Going for emotion: Pharma takes a page from consumer marketers for Olympic ads

Beth Snyder Bulik / FiercePharmaMarketing

Olympic Games marketers have a long history of crafting emotional TV ads that “soft sell” brands or companies. Themes like determination, family, triumph over adversity, and patriotism often result in heartwarming, dramatic and even cinematic TV commercials.

Pharma brings the heat in July as TV ad spending soars

Beth Snyder Bulik / FiercePharmaMarketing

Pharma marketers must have missed the memo about the dog days of summer. TV spending by the top 10 pharma advertisers topped $140 million, making the total for July the highest since January, according to data from real-time TV ad tracker iSpot.tv.

"Take your pills" says connected package

Julien Happich / EE Times Europe

According to Lux Research, smart’ pills and connected patches could save $290 Billion in U.S. Health care costs, through better medication adherence.

09 August 2016

Syndax Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update

 Syndax Pharmaceuticals (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing entinostat and SNDX-6352 in multiple cancer indications, today reported its financial results for the second quarter ended June 30, 2016 and provided a pipeline update as well as a review of upcoming milestones.  As of June 30, 2016, Syndax had $125.5 million in cash, cash equivalents and short-term investments.

09 August 2016

Tobira Therapeutics Reports Second Quarter 2016 Financial and Business Results

Tobira Therapeutics, Inc.  ( NASDAQ : TBRA) a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases, today reported business highlights and financial results for the three months ended  June 30, 2016 .

09 August 2016

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2016 Financial Results

Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update and announced its financial results for the second quarter ended June 30, 2016.